Identifying solutions to psychological insulin resistance: An international study

Authors: Polonsky WH, Fisher L, Hessler D, Stuckey H, Snoek FJ, Tang T, Hermanns N, Mundet X, Silva M, Sturt J, Okazaki K, Hadjiyianni I, Cao D, Ivanova J, Desai U, Perez-Nieves M

Abstract

Aims: To identify actions of healthcare professionals (HCPs) that facilitate the transition to insulin therapy (IT) in type 2 diabetes (T2D) adults.

Methods: Included were T2Ds in seven countries (n = 594) who reported initial IT reluctance but eventually began IT. An online survey included 38 possible HCP actions: T2Ds indicated which may have occurred and their helpfulness. Also reported were delays in IT start after initial recommendation and any period of IT discontinuation.

Results: Exploratory factor analysis of HCP actions yielded five factors: “Explained Insulin Benefits” (EIB), “Dispelled Insulin Myths” (DIM), “Demonstrated the Injection Process” (DIP), “Collaborative Style” (CS) and “Authoritarian Style” (AS). Highest levels of helpfulness occurred for DIP, EIB and CS; lowest for AS. Participants who rated DIP as helpful were less likely to delay IT than those who rated DIP as less helpful (OR = 0.75, p = 0.01); participants who rated CS and EIB as helpful were less likely to interrupt IT than those who rated these as less helpful (OR = 0.55, p < 0.01; OR = 0.51, p = 0.01, respectively).

Conclusions: Three key HCP actions to facilitate IT initiation were identified as helpful and were associated with more successful initiation and persistence. These findings may aid the development of interventions to address reluctance to initiating IT.

Source: https://pubmed.ncbi.nlm.nih.gov/30709604/

Share the Post:

BDI Monthly Events

January 26
January 26Virtual Presentation
January 26: Dr. Guzman (BDI Director of Clinical Education) will virtually present “The Emotional Side of Diabetes” to the CDCES team at Weill Cornell Medicine in NYC.
January 6
January 6Panel Presentation
January 6: Dr. Polonsky (BDI President) will be joining the panel presentation, “The Rise of Liveable Tech: Calm, Intelligent and Human-First”, at CES 2026, in Las Vegas (NV). https://www.ces.tech/schedule/the-rise-of-liveable-tech-calm-intelligent-and-human-first-presented-by-insulet/
January 14
January 14Case Consultation
January 14: BDI hosts the San Diego-wide, monthly case consultation meeting (for mental health professionals working in the field of diabetes). Contact us at [email protected] if you are in the greater San Diego area and would like further information about this program.